Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome
Authors:
- Jie QiaoJQJie Qiao
- Yan YangYYYan Yang
- Lina WangLWLina Wang
- Rong LiRLRong Li
- 1 July 2011
- journal article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 157 (1) , 53-56
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Polycystic Ovary SyndromeObstetrics & Gynecology, 2004
- Molecular Mechanisms Mediating Inflammation in Vascular DiseaseHypertension, 2003
- Preactivated monocytes from hypertensive patients as a factor for atherosclerosis?Atherosclerosis, 2001
- Modulation of C-Reactive Protein–Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis DrugsCirculation, 2001
- Novel Risk Factors for Systemic AtherosclerosisJAMA, 2001
- High-Sensitivity C-Reactive ProteinCirculation, 2001
- Monocyte Chemoattractant Protein-1 Accelerates Atherosclerosis in Apolipoprotein E-Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Coronary Heart Disease Risk Factors in Women With Polycystic Ovary SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of womenActa Obstetricia et Gynecologica Scandinavica, 1992
- Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndromeClinical Endocrinology, 1992